[1]
Bektur, C. and Nurgozhin, T. 2014. Cost-effectiveness Analysis of Denosumab in the Prevention of Skeletal-related Events in Patients with Prostate Cancer in Kazakhstan. Central Asian Journal of Global Health. 3, (Dec. 2014). DOI:https://doi.org/10.5195/cajgh.2014.154.